Treating type 2 diabetes patients as early as possible by controlling blood sugar with insulin and drugs can prolong life and reduce the risk of future complications such as heart attacks, kidney failure and vision loss, according to long-running research.
Scientists from the Universities of Oxford and Edinburgh analysed data spanning more than four decades from the UK Prospective Diabetes Study (UKPDS) – one of the longest type 2 diabetes clinical trials.
